CMMB Chemomab Therapeutics Ltd.

Healthcare

$2.02+9.37%ClosedMarket Cap: $12.4M

As of 2026-05-25

Analyst Consensus

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2025-08-27	Oppenheimer	maintain	Outperform	Outperform

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.03	$36.2M	1
Sun Dec 31	$-0.04	$0.00	1
Mon Dec 31	$-0.04	$35.5M	1
Tue Dec 31	$-0.04	$36.2M	1